G

Gotham Therapeutics

2 employees

Gotham Therapeutics is discovering a novel drug class targeting the epitranscriptomics machinery.

Basic info

Industry

biotechnology research

Sectors

Biotechnology
Therapeutics
Life Science

Date founded

2017

Funding rounds raised

Total raised

$54M

from 3 investors over 3 rounds

G

Gotham Therapeutics raised $54M on October 10, 2018

Investors: Forbion, Versant Ventures and S.R. One Ltd

FAQ